Delisting risk
Matinas BioPharma (MTNB)
Developer of lipid nanocrystal delivery technology for oral antifungal treatment.
$0.2047
Pre-market+0.02 (+7.91%)
At close$0.1897(−4.05%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions28 holders · as of Mar 31, 2026 | 2.41% | 354.4K shares | |
| Insiders1 holder · as of Aug 13, 2026 | 7.90% | 1.16M shares | |
| Strategic holders1 holder · as of Jul 14, 2026 | 8.89% | 1.31M shares | |
| Otherremainder | 80.80% | 11.87M shares |
14.69M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (14.69M in the company's Sep 3, 2026 report, 6.41M elsewhere); stakes use the report.
Institutions13F, as of Mar 31, 2026
28 holders · 354.4K shares · 5 new positions · 7 increased · 7 reduced · 6 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Geode Capital Management, LLC | 65.2K | 0.44% | +9.2K | May 15, 2026 |
| Citadel Advisors LLC | 51.7K | 0.35% | −14.0K | May 15, 2026 |
| BlackRock, Inc. | 49.7K | 0.34% | 0 | May 13, 2026 |
| Vanguard Capital Management LLC | 40.1K | 0.27% | +40.1Knew | May 15, 2026 |
| Holos Integrated Wealth LLC | 32.5K | 0.22% | 0 | Apr 8, 2026 |
| Renaissance Technologies LLC | 28.6K | 0.19% | −400 | May 14, 2026 |
| XTX Topco Ltd | 20.7K | 0.14% | +3.8K | May 15, 2026 |
| Vanguard Fiduciary Trust Co | 18.3K | 0.12% | +18.3Knew | May 8, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Stern Adam Kincl. Sanitam Partners LLC | 9.99% | 2.97M | 13D | Aug 13, 2026 ↗ |
| Robert J. Eideincl. Pembroke & Partners LLC | 9.99% | 13D | Apr 10, 2025 ↗ | |
| Highbridge Capital Management, LLC | 9.99% | 595.6K | 13G | Oct 25, 2024 ↗ |
| Lazar David E. | 9.81% | 545.0K | 13G | Aug 19, 2025 ↗ |
| Hezbay Holdings LLC | 9.54% | 1.31M | 13G | Jul 14, 2026 ↗ |
Insider tradesForm 4
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.
